Gaucher Disease—Correlation of Lyso-Gb1 with Haematology and Biochemical Parameters
<b>Background/Objectives</b>: Gaucher disease (GD) is a lysosomal disorder caused by a deficiency of β-glucosidase. Disease-modifying therapies (DMTs) include enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). Glucosylsphingosine (lyso-Gb1) is a biomarker with high sensitivity a...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-11-01
|
| Series: | Metabolites |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2218-1989/15/11/731 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
